“We need effective antibiotics to protect the health and future of our children”: Interview with CPME President Dr Ole Johan Bakke
To mark the theme of this year’s European Antibiotic Awareness Day, "Care for your kids - use antibiotics wisely", we interviewed our President, Dr Ole Johan Bakke who has over 35 years’ experience as a general practitioner and a public health officer. He explained why children are particularly vulnerable to antimicrobial resistance (AMR) and how health systems can better support them.
Why are antibiotics important for children?
Children often have more infections, so they need effective antibiotics. Their immune systems are not fully developed, so they are more dependent on healthcare and medication for some infectious diseases.
Very often children are more subject to viral infections, but they may also be bacterial and need antibiotics from time to time.
Certain bacteria are evolving to resist treatment from antibiotics, therefore we need to implement strategies to keep these vital medicines working to treat our children.
How can health systems be organised to better protect children?
Continuity of care is very important, both for children and the population as a whole. As they are small, their condition can change or become aggravated more rapidly.
Young children cannot speak or fully express themselves, so they are more difficult to understand and interpret. Together with their parents, you have to follow them thoroughly to see how the infection develops, and to judge whether the child needs antibiotics or not.
If a doctor or health service does not have any possibility of seeing the child again in the days following the consultation, then they are more likely to prescribe antibiotics to make sure that the child will be treated if needed.
On the other hand, if we organise healthcare in a way that the same doctor and/or service can follow up with the patient to evaluate whether antibiotics are needed or not, then you can reduce the amount of antibiotics prescribed and then again the challenge of antimicrobial resistance.
This is an example where better access to healthcare combined with more continuity of care provides better health outcomes and reduces the overall financial cost to the health system.
Are there challenges to ensuring children have timely access to appropriate antibiotics?
When a doctor decides an antibiotic is necessary, it needs to be available to prescribe. In recent years, shortages of common antibiotics have posed a real challenge for doctors and can force them to prescribe antibiotics solely based on availability rather than suitability. This may result in worse patient outcomes and undermines efforts to fight AMR, as we want to prescribe as targeted antibiotics as possible. We need to increase our collaboration and communication across all actors in the supply chain to mitigate the impact of antibiotic shortages.
For many children, liquid antibiotics in syrups are preferable as they may struggle to swallow tablets safely or need doses based on their weight. However, liquid antibiotics can be more complicated and expensive to supply than tablets, for example, the expiration limits are shorter than tablets. This creates a wider stockpiling problem which impacts producers and pharmacists as well.
How can we make sure there are effective antibiotics in the future?
Our children will inherit the problem of increasing AMR across the world, and we have a responsibility to ensure that there are effective antibiotics for future generations.
The development and production of novel antibiotics is often not commercially attractive, as doctors try to prescribe as little as possible to reduce AMR. We need to encourage innovation, with balanced incentives.
This means that national health authorities and member states, should take much more responsibility for research and development and procurement of this specific part of the pharmaceutical system, because it is so important that we keep antibiotics working.